Intra-Cellular Therapies Inc (NAS:ITCI)
$ 68.8 -1.54 (-2.19%) Market Cap: 7.26 Bil Enterprise Value: 6.78 Bil PE Ratio: 0 PB Ratio: 11.21 GF Score: 57/100

Intra-Cellular Therapies Inc (ITCI) Stock Estimates Data

Intra-Cellular Therapies Inc (ITCI) 12 Month Price Targets

Intra-Cellular Therapies Inc (ITCI) Analyst Rating